A Data-Driven Approach for Leveraging Inline and Offline Data to Determine the Causes of Monoclonal Antibody Productivity Reduction in the Commercial-Scale Cell Culture Process

Author:

Zhang Sheng1ORCID,Chen Hang1,Wan Yuxiang2,Wang Haibin2,Qu Haibin1

Affiliation:

1. Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China

2. BioRay Pharmaceutical Co., Ltd., Taizhou 318000, China

Abstract

The monoclonal antibody (mAb) manufacturing process comes with high profits and high costs, and thus mAb productivity is of vital importance. However, many factors can impact the cell culture process, and lead to mAb productivity reduction. Nowadays, the biopharma industry is actively employing manufacturing information systems, which enable the integration of both online data and offline data. Although the volume of data is large, related data mining studies for mAb productivity improvement are rare. Therefore, a data-driven approach is proposed in this study to leverage both the inline and offline data of the cell culture process to discover the causes of mAb productivity reduction. The approach consists of four steps, namely data preprocessing, phase division, feature extraction and fusion, and cluster comparing. First, data quality issues are solved during the data preprocessing step. Next, the inline data are divided into several phases based on the moving window k-nearest neighbor method. Then, the inline data features are extracted via functional data analysis and combined with the offline data features. Finally, the causes of mAb productivity reduction are identified using the contrasting clusters via the principal component analysis method. A commercial-scale cell culture process case study is provided in this research to verify the effectiveness of the approach. Data from 35 batches were collected, and each batch contained nine inline variables and seven offline variables. The causes of mAb productivity reduction were identified to be the lack of nutrients, and recommended actions were taken according to the result, which was subsequently proven by six validation batches.

Funder

Key Research and Development Program of Zhejiang Province

Publisher

MDPI AG

Reference38 articles.

1. Biopharmaceutical benchmarks 2022;Walsh;Nat. Biotechnol.,2022

2. Top companies and drugs by sales in 2022;Urquhart;Nat. Rev. Drug Discov.,2023

3. Mordor Intelligence (2024, March 02). Biopharmaceutical Industry Size & Share Analysis—Growth Trends & Forecasts (2024–2029). Available online: https://www.mordorintelligence.com/industry-reports/global-biopharmaceuticals-market-industry.

4. Pörtner, R. (2021). Next Generation Cell Engineering Using microRNAs. Cell Culture Engineering and Technology: In Appreciation to Professor Mohamed Al-Rubeai, Springer International Publishing.

5. Hu, W. (2020). Cell Culture Bioprocess Engineering, CRC Press. [2nd ed.].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3